KFDA’s drug-related committee urged to provide more information

Published: 2010-10-13 07:00:00

Updated: 2010-10-13 07:00:00

The Korea Food and Drug Administration should provide key information on its Central Pharmaceutical Affairs Review Committee (CPARC) for selection of committee members and for details of various meetings.

So far, the KFDA has been given advice from the CPARC for a variety of drug-related admin...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK